We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REFR:NASDAQResearch Frontiers Incorporated Analysis

Data as of 2026-04-28 - not real-time

$0.95

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical analysis shows the 20‑day SMA (≈0.95) sitting below both the 50‑day SMA (≈0.97) and the 200‑day SMA (≈1.39), confirming a bearish price structure. The RSI is near 49, indicating a lack of clear momentum, while the MACD histogram is modestly positive, suggesting a brief bullish impulse that is outweighed by the broader downtrend. Volume is trending upward, yet the stock trades in a very narrow range between $0.94 and $0.99, far below its 52‑week high of $2.70. Fundamentals are deeply distressed: revenue has collapsed by roughly 60%, margins are negative across the board, and the company reports a max drawdown of over 66% with a negative EBITDA exceeding $2 million. Valuation multiples are extreme, with a price‑to‑book near 34 and a price‑to‑sales above 29, while earnings are negative, yielding a forward P/E of –15.8. The firm carries a high debt‑to‑equity ratio (>120) and a negative cash flow profile, raising solvency concerns. Beta (≈1.08) and a 30‑day volatility of nearly 97% signal pronounced price swings, and the Fear‑Greed Index at 89.25 reflects an “Extreme Greed” market mood that may be unsustainable for such a fragile ticker. No dividend is paid, eliminating any income cushion. In sum, the convergence of weak technical signals, severe fundamental deterioration, and elevated risk metrics paints a cautious outlook for REFR.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish SMA crossover
  • Negative earnings and cash flow
  • Elevated volatility and drawdown

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential for turnaround if capital structure improves
  • Technical support near $0.87
  • Uncertain market sentiment

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Long‑term industry exposure to smart glass technology
  • High valuation multiples remain unjustified
  • Continued debt burden limits upside

Key Metrics & Analysis

Financial Health

Revenue Growth-59.50%
Profit Margin-182.44%
P/E Ratio-15.8
ROE-115.64%
ROA-42.36%
Debt/Equity124.92
P/B Ratio33.9
Op. Cash Flow$-1329161
Free Cash Flow$-487032
Industry P/E38.2

Technical Analysis

TrendBearish
RSI48.8
Support$0.87
Resistance$1.02
MA 20$0.95
MA 50$0.97
MA 200$1.39
MACDBullish
VolumeIncreasing
Fear & Greed Index89.25

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta1.08
Volatility96.68%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.